Sustained treatment effect in attention-deficit/hyperactivity disorder: focus on long-term placebo-controlled randomized maintenance withdrawal and open-label studies

References

• KesslerRCAdlerLBarkleyRThe prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey ReplicationAm J Psychiatry2006163471672316585449
   PubMed Web of Science ®Google Scholar
• MichielsenMSemeijnEComijsHCPrevalence of attention-deficit hyperactivity disorder in older adults in The NetherlandsBr J Psychiatry201220129830522878132
   PubMed Web of Science ®Google Scholar
• Guldberg-KjarTJohanssonBOld people reporting childhood AD/HD symptoms: retrospectively self-rated AD/HD symptoms in a population-based Swedish sample aged 65–80Nord J Psychiatry200963537538219308795
   PubMed Web of Science ®Google Scholar
• BiedermanJFaraoneSMilbergerSPredictors of persistence and remission of ADHD into adolescence: results from a four-year prospective follow-up studyJ Am Acad Child Adolesc Psychiatry19963533433518714323
   PubMed Web of Science ®Google Scholar
• BiedermanJPettyCRClarkeALomedicoAFaraoneSVPredictors of persistent ADHD: an 11-year follow-up studyJ Psychiatr Res201145215015520656298
   PubMed Web of Science ®Google Scholar
• PliszkaSAACAP Work Group on Quality IssuesPractice parameter for the assessment and treatment of children and adolescents with attention- deficit/hyperactivity disorderJ Am Acad Child Adolesc Psychiatry200746789492117581453
   PubMed Web of Science ®Google Scholar
• BiedermanJPettyCREvansMSmallJFaraoneSVHow persistent is ADHD? A controlled 10-year follow-up study of boys with ADHDPsychiatry Res2010177329930420452063
   PubMed Web of Science ®Google Scholar
• LaraCFayyadJDe GraafRChildhood predictors of adult attention-deficit/hyperactivity disorder: results from the World Health Organization World Mental Health Survey InitiativeBiol Psychiatry2009651465419006789
   PubMed Web of Science ®Google Scholar
• KesslerRCGreenJGAdlerLAStructure and diagnosis of adult attention-deficit/hyperactivity disorder: analysis of expanded symptom criteria from the Adult ADHD Clinical Diagnostic ScaleArch Gen Psychiatry201067111168117821041618
   PubMed Web of Science ®Google Scholar
• ArnstenAFBerridgeCWMcCrackenJTThe neurological basis of attention-deficit/hyperactivity disorderPrim Psychiatry20091674754
   Google Scholar
• ValeraEMBrownABiedermanJSex differences in the functional neuroanatomy of working memory in adults with ADHDAm J Psychiatry20101671869419884224
   PubMed Web of Science ®Google Scholar
• MakrisNBiedermanJValeraEMCortical thinning of the attention and executive function networks in adults with attention-deficit/hyperactivity disorderCereb Cortex20071761364137516920883
   PubMed Web of Science ®Google Scholar
• Semrud-ClikemanMPliszkaSRBledsoeJLancasterJVolumetric MRI differences in treatment naive and chronically treated adolescents with ADHD-combined typeJ Atten Disord. Epub May 31, 2012
   Web of Science ®Google Scholar
• American Psychiatric AssociationAttention-deficit and disruptive behavior disordersAmerican Psychiatric AssociationDiagnostic and Statistical Manual of Mental Disorders4th Edition Text RevisionWashington, DCAmerican Psychiatric Association20008593
   Google Scholar
• BarkleyRADeficient emotional self-regulation: a core component of attention-deficit/hyperactivity disorderJ ADHD Related Disord201012537
   Google Scholar
• BanaschewskiTBeckerKScheragSFrankeBCoghillDMolecular genetics of attention-deficit/hyperactivity disorder: an overviewEur Child Adolesc Psychiatry201019323725720145962
   PubMed Web of Science ®Google Scholar
• FrankeBNealeBMFaraoneSVGenome-wide association studies in ADHDHum Genet20091261135019384554
   PubMed Web of Science ®Google Scholar
• PoelmansGPaulsDLBuitelaarJKFrankeBIntegrated genome-wide association study findings: identification of a neurodevelopmental network for attention deficit hyperactivity disorderAm J Psychiatry2011168436537721324949
   PubMed Web of Science ®Google Scholar
• BiedermanJPettyCRWilensTEFamilial risk analyses of attention deficit hyperactivity disorder and substance use disordersAm J Psychiatry2008165110711518006872
   PubMed Web of Science ®Google Scholar
• DurstonSFossellaJAMulderMJDopamine transporter genotype conveys familial risk of attention-deficit/hyperactivity disorder through striatal activationJ Am Acad Child Adolesc Psychiatry2008471616718174826
   PubMed Web of Science ®Google Scholar
• ShawPGilliamMLiverpoolMCortical development in typically developing children with symptoms of hyperactivity and impulsivity: support for a dimensional view of attention deficit hyperactivity disorderAm J Psychiatry2011168214315121159727
   PubMed Web of Science ®Google Scholar
• CastellanosFXProalELarge-scale brain systems in ADHD: beyond the prefrontal-striatal modelTrends Cogn Sci2012161172622169776
   PubMed Web of Science ®Google Scholar
• BushGCingulate, frontal, and parietal cortical dysfunction in attention-deficit/hyperactivity disorderBiol Psychiatry201169121160116721489409
   PubMed Web of Science ®Google Scholar
• Del CampoNChamberlainSRSahakianBJRobbinsTWThe roles of dopamine and noradrenaline in the pathophysiology and treatment of attention-deficit/hyperactivity disorderBiol Psychiatry20116912e145e15721550021
   PubMed Web of Science ®Google Scholar
• BiedermanJFriedRPettyCRCognitive development in adults with attention-deficit/hyperactivity disorder: a controlled study in medication-naive adults across the adult life cycleJ Clin Psychiatry2011721111621034681
   PubMed Web of Science ®Google Scholar
• Canadian ADHD Resource AllianceCanadian ADHD Practice Guidelines (CAP-Guidelines)3rd edTorontoCanadian Attention Deficit Hyperactivity Disorder Resource Alliance (CADDRA)2011 Available from: http://www.caddra.ca/cms4/pdfs/caddraGuidelines2011.pdfAccessed September 13, 2012
   Google Scholar
• National Collaborating Centre for Mental HealthAttention Deficit Hyperactivity Disorder: The NICE Guideline on Diagnosis and Management of ADHD in Children, Young People and AdultsLondonBritish Psychological Society; Royal College of Psychiatrists2009 Available from: http://www.nice.org.uk/nicemedia/pdf/ADHDFullGuideline.pdfAccessed September 19, 2012
   Google Scholar
• KooijSJBejerotSBlackwellAEuropean consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHDBMC Psychiatry2010106720815868
   PubMed Web of Science ®Google Scholar
• Intuniv (guanfacine) [package insert]Wayne, PAShire Pharmaceuticals Inc2011
   Google Scholar
• TurgayAGoodmanDWAshersonPLifespan persistence of ADHD: the life transition model and its applicationJ Clin Psychiatry201273219220122313720
   PubMed Web of Science ®Google Scholar
• BiedermanJMickEFaraoneSVAge-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom typeAm J Psychiatry2000157581681810784477
   PubMed Web of Science ®Google Scholar
• DasDCherbuinNButterworthPAnsteyKJEastealSA population- based study of attention deficit/hyperactivity disorder symptoms and associated impairment in middle-aged adultsPLoS One201272e3150022347487
   PubMed Web of Science ®Google Scholar
• AdlerLKesslerRCSpencerTAdult ADHD Self-Report Scale (ASRS-v11) Symptom Checklist InstructionsWorld Health Organization (WHO) Workgroup on Adult ADHD. Available from: http://webdoc.nyumc.org/nyumc/files/psych/attachments/psych_adhd_checklist.pdfAccessed October 28, 2012
   Google Scholar
• BiedermanJFaraoneSVSpencerTJMickEMonuteauxMCAleardiMFunctional impairments in adults with self-reports of diagnosed ADHD: a controlled study of 1001 adults in the communityJ Clin Psychiatry200667452454016669717
   PubMed Web of Science ®Google Scholar
• AbleSLJohnstonJAAdlerLASwindleRWFunctional and psychosocial impairment in adults with undiagnosed ADHDPsychol Med20073719710716938146
   PubMed Web of Science ®Google Scholar
• McCarthySAshersonPCoghillDAttention-deficit hyperactivity disorder: treatment discontinuation in adolescents and young adultsBr J Psychiatry2009194327327719252159
   PubMed Web of Science ®Google Scholar
• GoodmanDWThe consequences of attention-deficit/hyperactivity disorder in adultsJ Psychiatr Pract200713531832717890980
   PubMedGoogle Scholar
• BabinskiLMHartsoughCSLambertNMChildhood conduct problems, hyperactivity-impulsivity, and inattention as predictors of adult criminal activityJ Child Psychol Psychiatry199940334735510190336
   PubMed Web of Science ®Google Scholar
• Chronis-TuscanoAMolinaBSPelhamWEVery early predictors of adolescent depression and suicide attempts in children with attention-deficit/hyperactivity disorderArch Gen Psychiatry201067101044105120921120
   PubMed Web of Science ®Google Scholar
• MatzaLSParamoreCPrasadMA review of the economic burden of ADHDCost Eff Resour Alloc20053515946385
   PubMedGoogle Scholar
• PowersRLMarksDJMillerCJNewcornJHHalperinJMStimulant treatment in children with attention-deficit/hyperactivity disorder moderates adolescent academic outcomeJ Child Adolesc Psychopharmacol200818544945918928410
   PubMed Web of Science ®Google Scholar
• ShawMHodgkinsPCaciHA systematic review and analysis of long-term outcomes in attention deficit hyperactivity disorder: effects of treatment and non-treatmentBMC Med20121019922947230
   PubMed Web of Science ®Google Scholar
• CoghillDThe impact of medications on quality of life in attention-deficit hyperactivity disorder: a systematic reviewCNS Drugs2010241084386620839896
   PubMed Web of Science ®Google Scholar
• CoxDJMerkelRLKovatchevBSewardREffect of stimulant medication on driving performance of young adults with attention-deficit hyperactivity disorder: a preliminary double-blind placebo controlled trialJ Nerv Ment Dis2000188423023410790000
   PubMed Web of Science ®Google Scholar
• BiedermanJFriedRHammernessPThe effects of lisdexamfetamine dimesylate on the driving performance of young adults with ADHD: a randomized, double-blind, placebo-controlled study using a validated driving simulator paradigmJ Psychiatr Res201246448449122277301
   PubMed Web of Science ®Google Scholar
• Concerta (methylphenidate HCl) [package insert]Titusville, NJMcNeil Pediatrics2010
   Google Scholar
• Vyvanse (lisdexamfetamine dimesylate) [package insert]Wayne, PAShire US Inc2012
   Google Scholar
• Adderall XR (mixed salts of a single-entity amphetamine product) [package insert]Wayne, PAShire US Inc2010
   Google Scholar
• AdlerLDNierenbergAAReview of medication adherence in children and adults with ADHDPostgrad Med2010122118419120107302
   PubMed Web of Science ®Google Scholar
• WilensTMcBurnettKSteinMLernerMSpencerTWolraichMADHD treatment with once-daily OROS methylphenidate: final results from a long-term open-label studyJ Am Acad Child Adolesc Psychiatry200544101015102316175106
   PubMed Web of Science ®Google Scholar
• AdlerLAOrmanCStarrHLLong-term safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: an open-label, dose-titration, 1-year studyJ Clin Psychopharmacol201131110811421192153
   PubMed Web of Science ®Google Scholar
• BiedermanJSpencerTJWilensTEWeislerRHReadSCTullochSJon behalf of the SLI 381.304 Study GroupLong-term safety and effectiveness of mixed amphetamine salts extended release in adults with ADHDCNS Spectr20051012 suppl 20162516344837
   PubMed Web of Science ®Google Scholar
• FindlingRLChildressACKrishnanSMcGoughJJLong-term effectiveness and safety of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorderCNS Spectrums200813761462018622366
   PubMed Web of Science ®Google Scholar
• WeislerRYoungJMattinglyGGaoJSquiresLAdlerLon behalf of the 304 Study GroupLong-term safety and effectiveness of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorderCNS Spectr2009141057358520095369
   PubMed Web of Science ®Google Scholar
• MattinglyGWWeislerRHYoungJClinical response and symptomatic remission in short- and long-term trials of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorderBMC Psychiatry2013133923356790
   PubMed Web of Science ®Google Scholar
• FindlingRLCutlerAJSaylorKA long-term open-label safety and effectiveness trial of lisdexamfetamine dimesylate in adolescents with attention-deficit/hyperactivity disorderJ Child Adolesc Psychopharmacol201222532734223083020
   PubMed Web of Science ®Google Scholar
• AdlerLASpencerTJWilliamsDWMooreRJMichelsonDLong-term, open-label safety and efficacy of atomoxetine in adults with ADHD: final report of a 4-year studyJ Atten Disord20081224825318448861
   PubMed Web of Science ®Google Scholar
• KratochvilCJWilensTEGreenhillLLEffects of long-term atomoxetine treatment for young children with attention-deficit/hyperactivity disorderJ Am Acad Child Adolesc Psychiatry200645891992716865034
   PubMed Web of Science ®Google Scholar
• WilensTENewcornJHKratochvilCJLong-term atomoxetine treatment in adolescents with attention-deficit/hyperactivity disorderJ Pediatr2006149111211916860138
   PubMed Web of Science ®Google Scholar
• SalleeFRLyneAWigalTMcGoughJJLong-term safety and efficacy of guanfacine extended release in children and adolescents with attention- deficit/hyperactivity disorderJ Child Adolesc Psychopharmacol200919321522619519256
   PubMed Web of Science ®Google Scholar
• RubinJVinceBSalleeFLyneAYouchaSEffects of long-term open-label coadministration of guanfacine extended release and stimulants on core symptoms of ADHDProceedings of the 163rd Annual Meeting of the American Psychiatric AssociationMay 22–26, 2010New Orleans, LA, USA
   Google Scholar
• GoodmanDWGinsbergLWeislerRHCutlerAJHodgkinsPAn interim analysis of the Quality of Life, Effectiveness, Safety, and Tolerability (QU.E.S.T.) evaluation of mixed amphetamine salts extended release in adults with ADHDCNS Spectr20051012 suppl 20263416344838
   PubMed Web of Science ®Google Scholar
• AdlerLASpencerTJMiltonDRMooreRJMichelsonDLong-term, open-label study of the safety and efficacy of atomoxetine in adults with attention-deficit/hyperactivity disorder: an interim analysisJ Clin Psychiatry200566329429915766294
   PubMed Web of Science ®Google Scholar
• BiedermanJMelmedRDPatelAMcBurnettKDonahueJLyneALong-term, open-label extension study of guanfacine extended release in children and adolescents with ADHDCNS Spectr200813121047105519179940
   PubMed Web of Science ®Google Scholar
• AranoISugimotoTHamasakiTOhnoYPractical application of cure mixture model for long-term censored survivor data from a withdrawal clinical trial of patients with major depressive disorderBMC Med Res Methodol2010103320412598
   PubMed Web of Science ®Google Scholar
• LeonardiCLKimballABPappKAEfficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, doubleblind, placebo- controlled trial (PHOENIX 1)Lancet200837196251665167418486739
   PubMed Web of Science ®Google Scholar
• BiedermanJMickESurmanCA randomized, 3-phase, 34-week, double-blind, long-term efficacy study of osmotic-release oral system-methylphenidate in adults with attention-deficit/hyperactivity disorderJ Clin Psychopharmacol201030554955320814332
   PubMed Web of Science ®Google Scholar
• MichelsonDBuitelaarJKDanckaertsMRelapse prevention in pediatric patients with ADHD treated with atomoxetine: a randomized, double-blind, placebo-controlled studyJ Am Acad Child Adolesc Psychiatry200443789690415213591
   PubMed Web of Science ®Google Scholar
• NolanEEGadowKDSprafkinJStimulant medication withdrawal during long-term therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorderPediatrics19991034 Pt 173073710103294
   PubMed Web of Science ®Google Scholar
• BramsMWeislerRFindlingRLMaintenance of efficacy of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: randomized withdrawal designJ Clin Psychiatry201273797798322780921
   PubMed Web of Science ®Google Scholar
• SpencerTJBiedermanJMickEAttention-deficit/hyperactivity disorder: diagnosis, lifespan, comorbidities, and neurobiologyJ Pediatr Psychol200732663164217556405
   PubMed Web of Science ®Google Scholar